Newsroom

Nine people at a topping-out ceremony on a construction site symbolically strike a wooden beam with hammers.

News

On 28 August 2026, the Helmholtz Institute for One Health (HIOH) celebrated the completion of the structural shell of its new research building at the Berthold-Beitz-Platz campus together with guests from science, politics – including Bettina Martin, Minister for Science of Mecklenburg-Western Pomerania – and partner institutions. The €38 million project is jointly funded by the state of Mecklenburg-Western Pomerania, which is contributing €26.5 million, and the federal government.

28.08.2026

HIOH

Group photo of 10 people in front of two HZI banners

News

Dennis Rohde, a member of the German Bundestag and Parliamentary State Secretary at the Federal Ministry of Finance (BMF), visited the Braunschweig campus of the Helmholtz Centre for Infection Research (HZI) today. He was accompanied by Braunschweig’s Mayor, Dr. Thorsten Kornblum. The visit focused on discussions with the HZI management and researchers as well as insights into key research and infrastructure areas at the HZI.

26.08.2026

HZI Campus

News

Ebola viruses are among the most dangerous known human pathogens. Three species of Ebola virus have repeatedly caused major outbreaks on the African continent. Most outbreaks have been caused by the Zaire Ebola virus. Medicines and vaccines are available for this virus species. However, there are as yet no treatments or vaccines against the Bundibugyo Ebola virus, which is causing the current outbreak in the Democratic Republic of the Congo. This makes it considerably more difficult to combat the outbreak, which is already the largest Bundibugyo Ebola virus outbreak ever documented. A team of researchers at the German Primate Centre – Leibniz Institute for Primate Research (DPZ), at TWINCORE Centre for Experimental and Clinical Infection Research in Hannover, as well as at the University Medical Centre Hamburg-Eppendorf and the Charité – University Medicine Berlin has now investigated how the Bundibugyo Ebola virus enters cells and whether there is cross-protection from an already approved Zaire Ebola virus vaccine. The study was published in the journal The Lancet Infectious Diseases.

25.08.2026

TWINCORE

A scientist operates a bioreactor in the lab

News

The DZIF flagship project PANTIPA has reached an important milestone. Following successful preclinical work at the University Hospital Cologne and the Helmholtz Centre for Infection Research (HZI), the project is now entering the next stage of development, including process development and GMP-compliant manufacturing of a monoclonal antibody targeting Pseudomonas aeruginosa. The Celonic Group has been selected as a partner for process development and production. The goal of PANTIPA is to advance an innovative antibody therapy to the clinical trial stage, thereby creating new treatment options for patients with severe infections.

25.08.2026

HZI Campus

Two people in the lab, smiling at the camera

News

The SARS-CoV-2 coronavirus is constantly mutating. As a result, vaccines become less effective and need to be regularly adapted. This was the case in 2025 with the JN.1 variant. An interdisciplinary team from Hannover and Göttingen has now investigated how the immune system responds to adapted vaccines. The findings were published in Nature Communications.

17.08.2026

TWINCORE

Two petri dishes containing myxobacteria are held aloft, one in each hand

News

Most antibiotics used clinically are based on natural compounds produced by bacteria and other microorganisms. At the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS), researchers are using soil-dwelling myxobacteria as a source of new active ingredients. They are able to discover new active compounds primarily in bacteria that have not yet been extensively studied. Through decades of work, a HIPS research team has significantly expanded the biological diversity of myxobacteria. They are now making these microorganisms and their genetic data available to the entire research community, as they provide the basis for the discovery of new bioactive compounds. The researchers published their findings in the journal Advanced Science.

12.08.2026

HIPS

HZI in the media

... die klinische Validität. Ein Forschungsteam des Helmholtz-Zentrums für Infektionsforschung (HZI) hat mit „Metax“ nun einen ...

02.10.2026

Analytik.de

Mikrobiologen auch Kolleg*innen vom IST Austria und dem HZI in Braunschweig gehören: Inhibitoren von Aktin unterbinden diese dynamischen

01.10.2026

Science.apa.at

... der Medizinischen Hochschule Hannover sowie am Helmholtz-Zentrum für Infektionsforschung tätig ist. Als Co-Autor ist zudem ...

30.09.2026

Ad Hoc News

also included Japanese microbiologists and collaborators from IST Austria and HZI Braunschweig (Germany), demonstrated that actin inhibitors

30.09.2026

Phys.org

for cell movement. Scientists from the Helmholtz Center for Infection Research (HZI) in Braunschweig have provided evidence that Profilin

29.09.2026

TakeToNews

Biology (BRICS), a joint research center of the Helmholtz Centre for Infection Research (HZI) and Technische Universität Braunschweig.

29.09.2026

Phys.org

... treffsicher .

Das Helmholtz-Zentrum für Infektionsforschung:

Wissenschaftler:innen am Helmholtz-Zentrum für Infektionsforschung (HZI) ...

28.09.2026

DeutschesGesundheitsPortal

... Fluorchinolon-Resistenz aktiv

Forscher des Helmholtz-Zentrums für Infektionsforschung (HZI) um Dr. Jennifer Herrmann haben ...

27.09.2026

scinexx - Das Wissensmagazin

Die WHO nennt Antibiotikaresistenzen (AMR) eine der größten globalen Gesundheitsbedrohungen. Bereits heute töten resistente Keime jährlich mehr als eine Million Menschen direkt und tragen zu fast fünf Millionen Todesfällen bei. Tendenz: steigend. Für ein wirkungsvolles Dagegenha

25.09.2026

Sysmex

... die Resistenzen": HZI-Podcast InFact mit Mark Brönstrup

Quelle: Helmholtz-Zentrum für Infektionsforschung (HZI)

Biodiversität ...

25.09.2026

Analytik NEWS

Quelle: Pressemitteilung

Helmholtz-Zentrum für Infektionsforschung

24.09.2026

LaborPraxis

Lange galt Dopamin als simples Glückshormon. Alena Buyx zeigt in ihrer Sendung, dass der Botenstoff ...

24.09.2026

3sat

Register now for the HZI newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.